To explore the potential of Chlamydia pneumoniae as a retinal biomarker for Alzheimer’s disease and other neurodegenerative diseases.
Key Findings:
Chlamydia pneumoniae is linked to inflammatory processes in the retina associated with Alzheimer's disease.
Retinal cell types involved in immune responses and neurovascular health are significantly affected by the infection.
Persistent infection can lead to chronic inflammation, impairing neuronal integrity and function.
Interpretation:
The findings suggest that retinal biomarkers could enhance the assessment of neurodegenerative diseases, providing insights into underlying inflammatory processes and cognitive decline.
Limitations:
Need for rigorous standardization and validation of retinal biomarkers across diverse cohorts.
Current findings are not definitive for Alzheimer's-specific diagnosis based on single retinal features.
Conclusion:
Retinal biomarkers may complement existing neurologic assessments, aiding in risk stratification and monitoring of cognitive decline, pending further research and clinical integration.
